COVID-19 Related Cerebrovascular Thromboembolic Complications in Three Young Patients

Khawaja Hassan Haroon1,2, Ahmad Muhammad1,2, Suhail Hussain1

  • 1Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar.

Case Reports in Neurology
|November 11, 2020
PubMed

Insights

Patients with Coronavirus disease 2019 (COVID-19) face a higher risk of developing blood clots. This increased thrombosis risk is linked to excessive inflammation and platelet activation caused by the SARS-CoV-2 virus.

Area of Science:

  • * Infectious Diseases and Virology
  • * Hematology and Thrombosis

Background:

  • * The global pandemic of Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, presents significant challenges to healthcare systems worldwide.
  • * COVID-19 is increasingly recognized for its association with coagulopathy, affecting both venous and arterial vascular systems.

Observation:

  • * Patients diagnosed with COVID-19 exhibit a heightened susceptibility to thrombotic events.
  • * The pathophysiology involves a complex interplay of excessive inflammation, platelet hyper-reactivity, and endothelial cell dysfunction.

Findings:

  • * SARS-CoV-2 infection triggers a pro-thrombotic state, increasing the risk of blood clot formation.
  • * Mechanisms contributing to COVID-19-related coagulopathy include systemic inflammation, platelet activation, endothelial injury, and venous stasis.

Implications:

  • * Understanding the mechanisms of COVID-19-associated thrombosis is crucial for developing effective prevention and treatment strategies.
  • * Clinical management of COVID-19 patients should consider the elevated risk of venous thromboembolism (VTE) and arterial thrombosis.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
139
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
148
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
299
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
148
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
136
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
99